Highlights and Quick Summary
- EBITDA Margin for the quarter ending September 30, 2022 was 20.32% (a -11.96% decrease compared to previous quarter)
- Year-over-year quarterly EBITDA Margin decreased by -26.08%
- Annual EBITDA Margin for 2022 was 23.91% (a 2.09% increase from previous year)
- Annual EBITDA Margin for 2021 was 23.42% (a 24.38% increase from previous year)
- Annual EBITDA Margin for 2020 was 18.83% (a -18.87% decrease from previous year)
- Twelve month EBITDA Margin ending September 30, 2022 was 23.91% (a 4.87% increase compared to previous quarter)
- Twelve month trailing EBITDA Margin increased by 10.85% year-over-year
Trailing EBITDA Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 23.91% | 22.8% | 22.61% | 21.57% |
Visit stockrow.com/BDX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBITDA Margin of Becton, Dickinson and Company
Most recent EBITDA Marginof BDX including historical data for past 10 years.Interactive Chart of EBITDA Margin of Becton, Dickinson and Company
Becton, Dickinson and Company EBITDA Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 20.32% | 23.08% | 24.15% | 23.91% |
| 2021 | 27.49% | 15.48% | 22.29% | 20.2% | 23.42% |
| 2020 | 33.81% | 5.27% | 23.16% | 21.3% | 18.83% |
| 2019 | 24.4% | 14.5% | 27.59% | 16.66% | 23.21% |
| 2018 | 34.83% | 25.94% | 25.22% | 17.53% | 21.82% |
| 2017 | 17.08% | 24.53% | 1.81% | 23.78% | 21.58% |
| 2016 | 36.69% | 11.45% | 24.64% | 24.29% | 20.38% |
| 2015 | 21.47% | 19.93% | 13.97% | 21.01% | 19.11% |
| 2014 | 23.79% | 24.98% | 27.21% | 24.66% | 25.67% |
| 2013 | 25.81% | 10.42% | 26.5% | 25.85% | 22.36% |
| 2012 | 27.42% | 26.25% | 28.87% | 26.5% | 26.84% |
Business Profile of Becton, Dickinson and Company
Sector: Healthcare
Industry: Medical Instruments & Supplies